Solving for disease dynamics to deliver new medicines
Cairn Biosciences discovers new medicines by mapping multiscale cell dynamics. Our proprietary COMPASS discovery platform unlocks exclusive routes to novel targets and drugs by navigating uncharted, complex and dynamic disease biology.
Using COMPASS, our diverse, multidisciplinary team of experts in drug discovery, disease biology, engineering and computation is pioneering a new drug discovery paradigm that utilizes our innovative simulations of living biology to deliver better therapeutics.
We are initially orienting COMPASS to the exciting challenge of discovering new drugs that overcome acquired resistance to targeted cancer therapies.
MEET THE TEAM
Mary Ludlam PhD
Founder & CEO
Established biopharma leader & serial drug discovery innovator.
Visionary pioneer of diverse novel technologies including synthetic & cell biology; high-throughput microscopy; preclinical in vivo imaging; microfluidics; solid state femtosecond lasers & computational analysis.
Critical role in several blockbuster oncology programs including venetoclax & polatuzumab
Susana Abreu Ribeiro PhD
Director Discovery Data;
Paris Site Head
Multidisciplinary expert & leader of cross-continental biology & data science teams in San Francisco & Paris.
Fearless cell biologist & tool builder experienced in AI/ML, CRISPR & high-content screening & synthetic biology.
Ron Vale (HHMI, UCSF) & Bill Earnshaw FRS (Wellcome Center, U. Edinburgh) lab alumna with substantial expertise in cellular dynamics & oncology.
Senior Research Associate
Junior Data Engineer
CAREERS @ CAIRN
Would you be a perfect fit for Cairn Biosciences?
If you think you could be a fantastic addition to the team, please explore our current openings and get in touch with us.